continu
increas
mer
case
pose
seriou
threat
public
health
worldwid
call
develop
safe
effect
mer
vaccin
previous
shown
recombin
protein
contain
residu
merscov
receptorbind
domain
rbd
fuse
human
fc
induc
highli
potent
antimerscov
neutral
antibodi
presenc
adjuv
optim
dose
use
adjuv
order
elicit
strong
immun
respons
minim
amount
antigen
result
show
mg
abl
induc
immun
mice
potent
humor
cellular
immun
respons
particularli
mg
elicit
strong
neutral
antibodi
respons
pseudotyp
live
merscov
similar
induc
mg
respect
result
suggest
rbdbase
subunit
mer
vaccin
candid
dose
low
one
mg
suffici
potent
induc
strong
humor
cellular
immun
respons
includ
neutral
antibodi
merscov
infect
thu
provid
guidanc
determin
optim
dosag
rbdbase
mer
vaccin
futur
clinic
trial
appli
dosespar
strategi
subunit
vaccin
trial
wwwtandfonlinecom
middl
east
respiratori
syndrom
mer
newli
emerg
infecti
diseas
caus
mer
coronaviru
merscov
first
report
saudi
arabia
viru
identifi
countri
world
led
infect
individu
death
worldwid
mortal
rate
http
wwwwhointcsr
studi
indic
bat
camel
natur
reservoir
intermedi
transmiss
host
merscov
respect
moreov
elucid
battohuman
transmiss
mechan
merscov
merscov
caus
diseas
sever
famili
cluster
healthcar
worker
continu
increas
human
case
merscov
pose
seriou
threat
public
health
worldwid
demonstr
need
develop
safe
effect
vaccin
viru
infect
merscov
spike
protein
play
signific
role
mediat
viru
entri
target
cell
express
viral
receptor
dipeptidyl
peptidas
subsequ
fusion
viru
cell
membran
accomplish
merscov
depend
receptorbind
domain
rbd
subunit
bind
host
cellular
receptor
rbd
import
target
develop
mer
vaccin
previou
studi
map
rbd
region
contain
residu
merscov
protein
known
fragment
contain
residu
merscov
rbd
critic
neutral
domain
compar
differ
rbd
fragment
respect
contain
residu
merscov
protein
fuse
fc
human
igg
name
found
induc
highest
antibodi
respons
neutral
antibodi
immun
anim
promot
immunogen
aforement
demonstr
ideal
adjuv
use
protein
howev
minim
dose
rbd
protein
requir
induc
suffici
immun
respons
merscov
infect
remain
elucid
call
optim
antigen
dose
mer
subunit
vaccin
studi
examin
immun
potenti
differ
dose
compar
abil
induc
specif
humor
cellular
immun
respons
particularli
neutral
antibodi
infect
merscov
use
model
antigen
select
adjuv
mg
abl
induc
strong
humor
immun
respons
optim
dose
requir
induc
suffici
antibodi
respons
immun
mice
mg
respect
detect
specif
igg
antibodi
well
subtyp
immun
mous
sera
shown
figur
test
dose
abl
induc
merscov
igg
antibodi
respons
antibodi
rapidli
reach
high
level
immun
maintain
similar
level
thereaft
suggest
dose
formul
adjuv
suffici
induc
strong
antibodi
respons
expect
background
level
igg
antibodi
respons
induc
adjuv
group
mg
calcul
compar
endpoint
igg
titer
sera
mice
immun
rbd
dose
result
shown
figur
reveal
mg
induc
high
level
igg
antibodi
respons
respons
significantli
increas
mice
receiv
mg
nevertheless
signific
differ
observ
igg
titer
mg
immun
group
expect
mice
receiv
adjuv
mg
fail
induc
merscov
igg
antibodi
respons
fig
elucid
igg
subtyp
induc
differ
dose
detect
product
use
mous
sera
immun
shown
figur
high
titer
antibodi
induc
mg
howev
mg
induc
significantli
higher
level
antibodi
mg
fig
notabl
signific
differ
reveal
titer
antibodi
induc
mg
mg
appear
elicit
stronger
antibodi
either
mg
fig
expect
igg
subtyp
induc
adjuv
control
group
fig
result
suggest
mg
suffici
induc
high
titer
rbdspecif
antibodi
respons
although
mg
could
induc
higher
titer
total
igg
subtyp
mg
increas
level
igg
may
necessarili
provid
stronger
neutral
antibodi
respons
requir
protect
anim
merscov
infect
mg
induc
high
level
neutral
antibodi
respons
similar
induc
mg
immun
mice
elucid
neutral
potenti
induc
differ
dose
determin
minim
dose
mice
immun
without
mg
mg
sera
assess
merscov
igg
antibodi
elisa
igg
test
sera
dilut
mice
preimmun
posteach
immun
data
present
mean
standard
deviat
sd
mice
group
b
sera
postlast
immun
test
igg
titer
express
endpoint
dilut
remain
posit
detect
data
present
mean
titer
sd
mice
group
signific
differ
note
group
immun
mg
respect
mg
merscov
rbd
antigen
requir
elicit
strong
neutral
merscov
infect
investig
neutral
antibodi
mous
sera
immun
base
mer
pseudoviru
live
merscov
neutral
assay
result
shown
figur
demonstr
dose
test
abl
induc
potent
neutral
antibodi
titer
infect
mer
pseudoviru
cell
fig
live
merscov
vero
cell
fig
signific
differ
neutral
activ
among
sera
mice
immun
mg
respect
presenc
adjuv
sera
adjuv
control
mice
mg
show
neutral
activ
fig
data
suggest
mg
concentr
abl
induc
suffici
merscov
neutral
antibodi
immun
mice
compar
cellular
immun
respons
induc
differ
dose
immun
mice
protein
mg
respect
detect
merscov
ifngexpress
cell
mous
splenocyt
collect
immun
shown
figur
mg
capabl
induc
strong
ifn
figur
comparison
antibodi
subtyp
induc
differ
antigen
dose
mice
immun
without
mg
mg
sera
postlast
immun
test
merscov
subtyp
elisa
titer
express
endpoint
dilut
remain
posit
detect
valu
present
mean
sd
mice
group
signific
differ
note
respons
group
immun
mg
respect
mg
merscov
rbd
gexpress
cell
c
fig
c
fig
popul
increas
dose
mg
induc
higher
cell
respons
addit
mg
fail
elicit
strong
c
c
cell
expect
adjuv
control
group
mg
induc
background
level
specif
cell
respons
result
suggest
mg
suffici
induc
potent
ifngexpress
cell
respons
immun
mice
develop
effect
vaccin
urgent
need
prevent
continu
epidem
mer
current
sever
mer
vaccin
candid
test
preclin
set
show
immunogen
report
modifi
vaccinia
viru
ankara
mva
express
fulllength
protein
adenovirus
encod
fulllength
protein
subunit
induc
sspecif
antibodi
respons
neutral
merscov
infect
vitro
indic
potenti
develop
viral
vectorbas
mer
vaccin
nanoparticleconjug
fulllength
protein
elicit
neutral
antibodi
mice
bring
hope
develop
nanoparticlebas
mer
vaccin
engin
replicationcompet
propagationdefect
merscov
provid
platform
develop
attenu
virus
mer
vaccin
candid
other
identifi
sever
protein
fragment
includ
residu
rbd
merscov
protein
induc
neutral
antibodi
mice
rabbit
suggest
potenti
develop
subunit
vaccin
merscov
among
variou
vaccin
type
base
inactiv
liveattenu
virus
viral
vector
recombin
proteinbas
subunit
vaccin
consid
safest
type
vaccin
viru
infect
howev
efficaci
subunit
vaccin
larg
depend
identif
suitabl
antigen
select
appropri
adjuv
shown
recombin
protein
contain
residu
merscov
rbd
elicit
highest
neutral
antibodi
among
rbd
fragment
test
merscov
infect
addit
demonstr
potent
among
adjuv
includ
freund
aluminum
monophosphoryl
lipid
montanid
augment
immunogen
induc
strong
antibodi
respons
neutral
antibodi
protect
merscov
infect
suggest
ideal
adjuv
merscov
rbdbase
subunit
vaccin
apart
antigen
adjuv
equal
crucial
often
neglect
aspect
immun
optim
antigen
dosag
find
minim
antigen
dose
abl
induc
strong
immun
respons
studi
compar
level
immun
respons
mice
immun
mg
respect
formul
adjuv
rang
dose
select
base
previou
studi
show
mg
protein
induc
strong
immun
respons
neutral
activ
protect
vaccin
mice
challeng
merscov
found
mg
abl
elicit
strong
humor
cellular
immun
respons
immun
mice
particularli
protein
mg
induc
high
level
neutral
antibodi
infect
mer
pseudoviru
live
merscov
similar
induc
mg
respect
suggest
mg
formul
suffici
induc
strong
neutral
antibodi
respons
capabl
protect
mice
merscov
challeng
induc
mg
formul
previou
studi
therefor
test
actual
need
achiev
efficaci
prevent
merscov
infect
vaccin
mice
base
result
present
studi
applic
lowest
possibl
amount
antigen
fewer
inject
import
dose
spare
strategi
vaccin
low
product
eg
subunit
vaccin
especi
pandem
epidem
emerg
infecti
diseas
like
mer
studi
provid
import
inform
ration
design
optim
dosag
vaccin
mer
emerg
infecti
diseas
futur
clinic
trial
fourto
sixweekold
femal
balbc
mice
use
studi
anim
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
anim
protocol
approv
committe
ethic
anim
experi
new
york
blood
center
permit
number
recombin
contain
residu
merscov
spike
plu
ctermin
fc
tag
hereinaft
name
rbd
use
antigen
optim
antigen
dose
rbdbase
subunit
vaccin
construct
express
purif
describ
previous
fuse
rbd
gene
human
igg
fc
invivogen
san
diego
ca
express
protein
cell
cultur
supernat
purifi
protein
affin
chromatographi
ge
healthcar
piscataway
nj
merscov
protein
residu
plu
ctermin
construct
use
express
vector
jiangsu
taizhou
haiyuan
protein
biotech
co
ltd
china
express
cell
cultur
supernat
purifi
use
ninta
superflow
qiagen
valencia
ca
anim
immun
sampl
collect
mice
immun
previous
describ
modif
briefli
mice
subcutan
primeimmun
mg
respect
presenc
adjuv
boost
twice
immunogen
adjuv
interv
adjuv
without
antigen
mg
includ
neg
control
sera
collect
immun
posteach
vaccin
assess
merscov
antibodi
respons
neutral
antibodi
immun
mice
sacrif
last
immun
splenocyt
collect
detect
merscov
cell
respons
elisa
use
test
merscov
antibodi
respons
mous
sera
base
previous
describ
protocol
briefli
elisa
plate
precoat
merscov
protein
overnight
c
follow
addit
serial
dilut
sera
incub
c
h
four
wash
pbst
plate
incub
horseradish
peroxidas
hrp
conjug
antimous
igg
ge
healthcar
invitrogen
carlsbad
ca
respect
c
h
wash
time
reaction
visual
substrat
tetramethylbenzidin
tmb
invitrogen
carlsbad
ca
stop
n
h
absorb
nm
measur
elisa
plate
reader
tecan
san
jose
ca
done
previous
describ
modif
briefli
cell
cotransfect
plasmid
encod
envdefect
luciferaseexpress
genom
plasmid
encod
merscov
strain
protein
use
calcium
phosphat
method
cell
chang
fresh
dmem
h
later
pseudoviruscontain
supernat
harvest
h
posttransfect
singlecycl
infect
cell
pseudoviru
incub
serial
dilut
mous
sera
c
h
ad
cell
preplat
cultur
plate
twentyfour
hour
later
cell
refe
fresh
medium
follow
lyse
cell
h
later
use
cell
lysi
buffer
promega
madison
wi
transfer
lysat
luminomet
plate
luciferas
substrat
promega
ad
plate
rel
luciferas
activ
determin
infinit
pro
lumin
tecan
mer
pseudoviru
neutral
calcul
express
neutral
antibodi
titer
nt
live
merscov
neutral
assay
standard
microneutr
assay
use
confirm
antimerscov
neutral
antibodi
previous
describ
briefli
mous
sera
dilut
serial
tissu
cultur
plate
incub
h
room
temperatur
infecti
merscov
transfer
vero
cell
seventytwo
hour
later
neutral
capac
serum
sampl
assess
determin
presenc
absenc
virusinduc
cytopath
effect
cpe
neutral
antibodi
titer
express
reciproc
highest
dilut
sera
complet
inhibit
virusinduc
cpe
least
well
nt
intracellular
cytokin
stain
flow
cytometri
analysi
merscov
cellular
immun
respons
evalu
immun
mice
intracellular
cytokin
stain
follow
flow
cytometr
analysi
previous
describ
briefli
mous
splenocyt
stimul
merscov
protein
h
c
co
presenc
golgiplug
tm
contain
brefeldin
mlml
bd
bioscienc
san
jose
ca
cell
stain
conjug
apc
antibodi
min
c
wash
cell
fix
use
cytofixcytoperm
tm
kit
bd
bioscienc
stain
fitc
ifng
pe
bd
bioscienc
antibodi
min
c
stain
cell
analyz
use
facscalibur
bd
bioscienc
facsdiva
softwar
bd
bioscienc
valu
present
mean
standard
deviat
sd
statist
signific
among
differ
vaccin
group
calcul
student
ttest
use
graphpad
prism
statist
softwar
p
valu
less
consid
statist
signific
potenti
conflict
interest
disclos
studi
support
china
nation
project
infecti
diseas
grant
nih
grant
intramur
fund
new
york
blood
center
